The Scientific World Journal / 2012 / Article / Tab 2

Research Article

A Neutral Risk on the Development of New-Onset Diabetes Mellitus (NODM) in Taiwanese Patients with Dyslipidaemia Treated with Fibrates

Table 2

Cox analysis of fibrate prescriptions in the population, 2005–2010.

VariablesUnadjustedAdjusteda
HR95% C.I. 𝑃 -valueHR95% C.I. 𝑃 -value

Fenofibrate0.910.64–1.310.6141.300.82–2.050.263
Gemfibrozil1.100.76–1.580.6140.7710.49–1.220.263

a A djusted for gender, age, and mean dose.
Multiple Cox regression models were used to estimate the relationship between sex, age, medication, and mean dose of fibrates and development of NODM.